Literature DB >> 27533065

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.

Clare Sun1, Jin Gao2, Laura Couzens2, Xin Tian3, Mohammed Z Farooqui1, Maryna C Eichelberger2, Adrian Wiestner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27533065      PMCID： PMC6421570          DOI： 10.1001/jamaoncol.2016.2437

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

Review 1.  The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.

Authors:  Adrian Wiestner
Journal:  Haematologica       Date:  2015-12       Impact factor: 9.941

Review 2.  Infections in patients with leukemia and lymphoma.

Authors:  Vicki A Morrison
Journal:  Cancer Treat Res       Date:  2014

3.  Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

Authors:  Carlos A DiazGranados; Andrew J Dunning; Murray Kimmel; Daniel Kirby; John Treanor; Avi Collins; Richard Pollak; Janet Christoff; John Earl; Victoria Landolfi; Earl Martin; Sanjay Gurunathan; Richard Nathan; David P Greenberg; Nadia G Tornieporth; Michael D Decker; H Keipp Talbot
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

Review 4.  Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia.

Authors:  Jennifer A Whitaker; Tait D Shanafelt; Gregory A Poland; Neil E Kay
Journal:  Clin Adv Hematol Oncol       Date:  2014-07

5.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113
  5 in total
  34 in total

1.  Ibrutinib may impair serological responses to influenza vaccination.

Authors:  Abby P Douglas; Jason A Trubiano; Ian Barr; Vivian Leung; Monica A Slavin; Constantine S Tam
Journal:  Haematologica       Date:  2017-06-28       Impact factor: 9.941

2.  BTK Inhibitors in Cancer Patients with COVID-19: "The Winner Will be the One Who Controls That Chaos" (Napoleon Bonaparte).

Authors:  Elise A Chong; Lindsey E Roeker; Mazyar Shadman; Matthew S Davids; Stephen J Schuster; Anthony R Mato
Journal:  Clin Cancer Res       Date:  2020-04-28       Impact factor: 12.531

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 4.  Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.

Authors:  Mini Kamboj; Monika K Shah
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

Review 5.  An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations.

Authors:  Bulent Kantarcioglu; Omer Iqbal; Joseph Lewis; Charles A Carter; Meharvan Singh; Fabio Lievano; Mark Ligocki; Walter Jeske; Cafer Adiguzel; Grigoris T Gerotziafas; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

Review 6.  Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.

Authors:  Christopher Pleyer; Adrian Wiestner; Clare Sun
Journal:  Leuk Lymphoma       Date:  2018-05-15

Review 7.  Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors:  Jan A Burger; Adrian Wiestner
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

8.  The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).

Authors:  Jennifer A Whitaker; Sameer A Parikh; Tait D Shanafelt; Neil E Kay; Richard B Kennedy; Diane E Grill; Krista M Goergen; Timothy G Call; Saad S Kendarian; Wei Ding; Gregory A Poland
Journal:  Vaccine       Date:  2021-01-16       Impact factor: 3.641

9.  COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.

Authors:  Lindsey E Roeker; David A Knorr; Meghan C Thompson; Mariely Nivar; Sonia Lebowitz; Nicole Peters; Isaac Deonarine; Saddia Momotaj; Saumya Sharan; Vanessa Chanlatte; Bianca Hampton; Liana Butala; Lindsay Amato; Angela Richford; Jessica Lunkenheimer; Kristen Battiato; Carissa Laudati; Anthony R Mato
Journal:  Leukemia       Date:  2021-05-13       Impact factor: 11.528

Review 10.  BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.

Authors:  Marzia Palma; Tom A Mulder; Anders Österborg
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.